NIR-Laser-Switched In Vivo Smart Nanocapsules for Synergic Photothermal and Chemotherapy of Tumors
NIR-Laser-Switched In Vivo Smart Nanocapsules for Synergic Photothermal and Chemotherapy of Tumors
复制标题
近红外激光开关体内智能纳米胶囊用于肿瘤的协同光热和化疗
DOI:
10.1002/adma.201502669
复制
发表时间:
2016-01-13
影响因子:
29.4
通讯作者:
Zhu, Meifang
中科院分区:
文献类型:
--
作者:
Meng, Zhouqi;Wei, Fang;Zhu, Meifang
Cu 2− xS [14] and WO 3− x [15] based nanoagents for the photothermal ablation of cancer cells in vivo. Nevertheless, it should be pointed out that NIR-PAT will cease immediately if the NIR laser irradiation is shut off. To further improve the therapeutic effects from chemotherapy or NIR-PAT, the combination of chemotherapy and NIR-PAT has attracted increasing attention, and several stimuli-responsive nanocomposites have been investigated, including PN@ liposome,[10b, 16] PN@ silica [17] and PN@ polymer,[18] Among these nanocomposites, PN@ polymer perhaps represents the most promising one, because the stimuli-responsive behavior of polymers has been demonstrated to be well regulated. For example, the low critical solution temperature (LCST) of polymer nanogels can be varied from 26 to 90 C.[19] Currently, several kinds of PN@ thermal-responsive polymers have been developed, such as polymer-based PN@ PNIPAM,[20] carbonbased PN@ PNIPAM [21] and noble-metal-based PN@ PEG/NIPAM,[18] which can deliver drugs under irradiation of an NIR laser, greatly improving chemo/photothermal therapy. It should be pointed out that for all these stimuli-responsive nanocomposites, the intelligent release (switching off/on) by NIR lasers is not yet well established due to the lack of or inadequacy of intelligent release systems. Therefore, it is still necessary to further develop smart nanocomposites that can be switched off/on controllably by an ex vivo NIR laser for simultaneous photothermal/chemotherapy of tumors. Here, we describe the design and fabrication of the “smart” MEO 2MA@ MEO 2MA-co-OEGMA-CuS-DOX composite (abbreviated as G-CuS-DOX), which consists of thermosensitive MEO 2MA@ MEO 2MA-co-OEGMA nanogels (abbreviated as G) with an LCST of 42 C, that serve as the nanocarriers, CuS nanoparticles as the photothermal component, and doxorubicin (DOX) as the anticancer drug (Figure 1a). G-CuS-DOX nanocapsules allow the application of photothermal therapy and drug release simultaneously, which can be switched off/on by an ex vivo NIR laser (Figure 2a). Subsequently, nanocapsules were injected into the tumor and close to cancer cells. Under irradiation with a 915-nm laser, cancer cells can be efficiently destroyed; both the tumor growth and metastasis lesions in liver tissue showed significant inhibition, indicating the excellent Synergic photothermal/chemotherapy effects compared to photothermal therapy or chemotherapy effect alone. The synthesis of G-CuS-DOX nanocapsules consisted of four steps, as demonstrated in Figure 1 a. The first step was to prepare a thermosensitive MEO 2MA nanogel (abbreviated as M) by a simple polymerization reaction (step 1 in Figure 1 a).[18b] M exhibits an average hydrodynamic diameter of≈ 90 nm (Figure S1a, Supporting Information) and an LCST of≈ 31 C (Figure S1b, Cancer poses a great threat to human health and life. Among cancer therapeutics, chemotherapy has been widely applied, in which the active drug should reach the tumor in vivo at the appropriate concentration, and administration of the drug should then be maintained for the required time to produce the therapeutic effect. To facilitate the delivery and dose control of drugs, advanced stimuli-responsive nanocarriers have recently received a great deal of attention. Stimuli-responsive nanocarriers are able to deliver drugs in response to specific stimuli, either endogenous variations (such as pH,[1] enzyme concentration, and redox gradients [2]) or exogenous stimuli (including temperature,[3] magnetic field,[4] ultrasound intensity,[5] light,[6] and electric pulses [7]). It should be noted that with …